WAYNE, Pa., Sept. 14, 2011 /PRNewswire/ -- The New York Stem Cell Summit is releasing effective today an Adult Stem Cell Fact Sheet to help the press and the general public understand more accurately the role that autologous stem cell therapies play in medicine in the United States today.
Approximately 1 million patients have been treated with their own stem cells since the mid-1980s in the United States.
Harvesting stem cells from adult patients and then re-injecting them into the same patient (autologous stem cell use) has been a routine therapy in U.S. medicine for decades. More recently, as stem cell research has developed, the precise method of harvesting, processing and then re-injecting into patients has changed and improved.
In this fact sheet, organizers of The New York Stem Cell Summit describe the purpose of autologous and allograft stem cells in medicine, the history of autologous stem cell therapies in the United States, the number of companies that are supplying equipment to facilitate autologous stem cell therapies in the United States, the size of this as a commercial business, the future of these therapies and then a short bibliography of clinical studies regarding the use of adult stem cells in the United States.
About the New York Stem Cell Summit
Founded in 2005, the New York Stem Cell Summit is the premier gathering of researchers, companies and venture firms interested in the rapidly growing stem cell industry. The New York Stem Cell Summit will be held February 21st at the Bridgewaters in lower Manhattan. For more information and registration go to www.stemcellsummit.com. The New York Stem Cell Summit is organized by RRY Publications, LLC. www.ryortho.com
CONTACT: Suzanne Kirchner, email@example.com, 888-749-2153
|SOURCE RRY Publications, LLC|
Copyright©2010 PR Newswire.
All rights reserved